Autopsy report · NCT03239470
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Cause of deathStaffing, sites or logistics, also slow enrollment
“Lack of recruitment, ongoing and new feasibility issues, and the impact of the coronavirus infectious disease 19 (COVID-19) pandemic”
Life of this trial
- Registered 2 months before it started.
- Ran for about 5 years 3 months before it stopped.
- 5 participants enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Sponsor type
- US National Institutes of Health
- Conditions
- Pemphigus Foliaceus; Pemphigus Vulgaris
- Interventions
- Cohort 1: 1.0 x 10^8 PolyTregs; Cohort 2: 2.5x10^8 PolyTregs
- Participants
- 5
- Sites
- 4
- Countries
- United States
Trials that died the same way
- Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery
“COVID-19 pandemic impacted recruitment” - The Interrogation of the Cardiomyopathy of Chronic Kidney Disease With advancEd caRdiac Imaging
“COVID-19 pandemic; pre-pandemic recruitment sufficient for scientific validity” - Pathology and Imaging in Kidney Allografts
“recruitment difficulties due to impact of COVID-19 pandemic” - Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation
“COVID-19 pandemic adversely affected recruitment.” - Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
“COVID-19 challenges to recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.